Details

Autor(en) / Beteiligte

• Dang, Anh-Thu Huynh
• Tran, Vu-Uyen
• Tran, Thanh-Truong
• Thi Pham, Hong-Anh
• Le, Dinh-Thong
• Nguyen, Lam
• Nguyen, Ngoc-Vu
• Thi Nguyen, Thai-Hoa
• Nguyen, Chu Van
• Le, Ha Thu
• Thi Nguyen, Mai-Lan
• Le, Vu Thuong
• Nguyen, Phuc Huu
• Vo, Binh Thanh
• Thi Dao, Hong-Thuy
• Nguyen, Luan Thanh
• Van Nguyen, Thien-Chi
• Bui, Quynh-Tram Nguyen
• Nguyen, Long Hung
• Nguyen, Nguyen Huu
• Thi Nguyen, Quynh-Tho
• Le, Truong Xuan
• Do, Thanh-Thuy Thi
• Dinh, Kiet Truong
• Do, Han Ngoc
• Phan, Minh-Duy
• Nguyen, Hoai-Nghia
• Tran, Le Son
• Giang, Hoa

Titel

Actionable Mutation Profiles of Non-Small Cell Lung Cancer patients from Vietnamese population

Ist Teil von

• Scientific reports, 2020-02, Vol.10 (1), p.2707-2707, Article 2707

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2020

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek (Open access)

Beschreibungen/Notizen

• Comprehensive profiling of actionable mutations in non-small cell lung cancer (NSCLC) is vital to guide targeted therapy, thereby improving the survival rate of patients. Despite the high incidence and mortality rate of NSCLC in Vietnam, the actionable mutation profiles of Vietnamese patients have not been thoroughly examined. Here, we employed massively parallel sequencing to identify alterations in major driver genes (EGFR, KRAS, NRAS, BRAF, ALK and ROS1) in 350 Vietnamese NSCLC patients. We showed that the Vietnamese NSCLC patients exhibited mutations most frequently in EGFR (35.4%) and KRAS (22.6%), followed by ALK (6.6%), ROS1 (3.1%), BRAF (2.3%) and NRAS (0.6%). Interestingly, the cohort of Vietnamese patients with advanced adenocarcinoma had higher prevalence of EGFR mutations than the Caucasian MSK-IMPACT cohort. Compared to the East Asian cohort, it had lower EGFR but higher KRAS mutation prevalence. We found that KRAS mutations were more commonly detected in male patients while EGFR mutations was more frequently found in female. Moreover, younger patients (<61 years) had higher genetic rearrangements in ALK or ROS1. In conclusions, our study revealed mutation profiles of 6 driver genes in the largest cohort of NSCLC patients in Vietnam to date, highlighting significant differences in mutation prevalence to other cohorts.